dineshyuvi

Title: dineshyuvi


1
Myhep all uses

• Myhep-All is the fixed dose combination of these
  two most widely used anti-viral agents.
• Sofosbuvir Velpatasvir are directly acting
  anti-viral agents which are involved in the
  treatment of chronic hepatitis C viral infection.
  
• Sofosbuvir is usually combined with other
  anti-viral agent for exhibiting the prominent
  effects.Myhep-All is the FDA approved product,
• which is used in chronic HCV condition. Myhep-All 
  should be used in genotype I, II, III, IV, V or
  VI associated hepatitis C viral infections.

2
Brand Name  Myhep-All Active components
 Sofosbuvir VelpatasvirPackage  28 tablets
in a containerManufactured by Mylan
pharmaceuticals Classified as Anti-viral drugs
3

• 
  PHARMACOKINETICS
• The maximum plasma concentration
  of Myhep-All is Sofosbuvir at 0.5 to 1 hour
  Velpatasvir at 3 hours Food does not affect the
  absorption of Myhep-All The Myhep-All tablet is
  highly bound to human plasma protein is
  Sofosbuvir 61 to 65 Velpatasvir by gt99.5 
• The blood plasma ratio of Sofosbuvir 0.7
  Velpatasvir 0.52 to 0.67. The Myhep-All metabolism
  is majorly occurs in liver sofosbuvir by
  cathepsin A or carboxyl esterase 1 Velpatasvir
  by CYP2B6, CYP2C8 or CYP3A4. 

4
PREGNANCYMyhep-All is probably safe to use and
its pregnancy category is B While concomitant
with ribavirin then the pregnancy category is X,
it is not used during pregnancy period.
5
91-9987711567

• info_at_myapplepharma.com